Indeed, it has been demonstrated that TLR3 activation by Poly(I:C) synergizes with 13-cis-retinoic acid in the treatment of high-risk neuroblastoma, through the activation of retinoic acid receptor beta (RARβ). The gene discussed is TLR3; the disease is neuroblastoma.